US6040138A
(en)
*
|
1995-09-15 |
2000-03-21 |
Affymetrix, Inc. |
Expression monitoring by hybridization to high density oligonucleotide arrays
|
US5470705A
(en)
*
|
1992-04-03 |
1995-11-28 |
Applied Biosystems, Inc. |
Probe composition containing a binding domain and polymer chain and methods of use
|
ATE173767T1
(de)
*
|
1992-04-03 |
1998-12-15 |
Perkin Elmer Corp |
Proben zusammensetzung und verfahren
|
US5605798A
(en)
|
1993-01-07 |
1997-02-25 |
Sequenom, Inc. |
DNA diagnostic based on mass spectrometry
|
JP3419850B2
(ja)
*
|
1993-10-26 |
2003-06-23 |
株式会社日立製作所 |
核酸分別方法
|
US5976798A
(en)
*
|
1994-03-30 |
1999-11-02 |
Mitokor |
Methods for detecting mitochondrial mutations diagnostic for Alzheimer's disease and methods for determining heteroplasmy of mitochondrial nucleic acid
|
ATE174066T1
(de)
*
|
1994-04-04 |
1998-12-15 |
Ciba Corning Diagnostics Corp |
Hybridisation-ligitation-verfahren zum nachweis von spezifischen dns sequenzen
|
US5807522A
(en)
*
|
1994-06-17 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for fabricating microarrays of biological samples
|
US7378236B1
(en)
|
1994-06-17 |
2008-05-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method for analyzing gene expression patterns
|
US7323298B1
(en)
*
|
1994-06-17 |
2008-01-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Microarray for determining the relative abundances of polynuceotide sequences
|
US5849483A
(en)
*
|
1994-07-28 |
1998-12-15 |
Ig Laboratories, Inc. |
High throughput screening method for sequences or genetic alterations in nucleic acids
|
US5834181A
(en)
*
|
1994-07-28 |
1998-11-10 |
Genzyme Corporation |
High throughput screening method for sequences or genetic alterations in nucleic acids
|
ATE226983T1
(de)
*
|
1994-08-19 |
2002-11-15 |
Pe Corp Ny |
Gekoppeltes ampflikation- und ligationverfahren
|
GB9417211D0
(en)
*
|
1994-08-25 |
1994-10-12 |
Solicitor For The Affairs Of H |
Nucleotide sequencing method
|
USRE43097E1
(en)
|
1994-10-13 |
2012-01-10 |
Illumina, Inc. |
Massively parallel signature sequencing by ligation of encoded adaptors
|
US6280935B1
(en)
|
1994-10-13 |
2001-08-28 |
Lynx Therapeutics, Inc. |
Method of detecting the presence or absence of a plurality of target sequences using oligonucleotide tags
|
US5846719A
(en)
|
1994-10-13 |
1998-12-08 |
Lynx Therapeutics, Inc. |
Oligonucleotide tags for sorting and identification
|
US8236493B2
(en)
*
|
1994-10-21 |
2012-08-07 |
Affymetrix, Inc. |
Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
|
DE19508366C2
(de)
*
|
1995-03-10 |
1998-01-29 |
Evotec Biosystems Gmbh |
Verfahren zum direkten Nachweisen weniger Nucleinsäurestränge
|
US5630924A
(en)
*
|
1995-04-20 |
1997-05-20 |
Perseptive Biosystems, Inc. |
Compositions, methods and apparatus for ultrafast electroseparation analysis
|
US5830655A
(en)
|
1995-05-22 |
1998-11-03 |
Sri International |
Oligonucleotide sizing using cleavable primers
|
HUP9900910A2
(hu)
*
|
1995-06-07 |
1999-07-28 |
Lynx Therapeutics, Inc. |
Oligonukleotid jelzések osztályozáshoz és azonosításhoz
|
US6613508B1
(en)
|
1996-01-23 |
2003-09-02 |
Qiagen Genomics, Inc. |
Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques
|
US6312893B1
(en)
|
1996-01-23 |
2001-11-06 |
Qiagen Genomics, Inc. |
Methods and compositions for determining the sequence of nucleic acid molecules
|
EP0880598A4
(de)
*
|
1996-01-23 |
2005-02-23 |
Affymetrix Inc |
Verfahren zur analyse von nukleinsäure
|
US6027890A
(en)
|
1996-01-23 |
2000-02-22 |
Rapigene, Inc. |
Methods and compositions for enhancing sensitivity in the analysis of biological-based assays
|
US6706471B1
(en)
|
1996-01-24 |
2004-03-16 |
Third Wave Technologies, Inc. |
Detection of nucleic acid sequences by invader-directed cleavage
|
US6852487B1
(en)
|
1996-02-09 |
2005-02-08 |
Cornell Research Foundation, Inc. |
Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
|
US6020481A
(en)
*
|
1996-04-01 |
2000-02-01 |
The Perkin-Elmer Corporation |
Asymmetric benzoxanthene dyes
|
EP0912761A4
(de)
|
1996-05-29 |
2004-06-09 |
Cornell Res Foundation Inc |
Bestimmung von unterschieden in der nukleisäuresequenz mittels einer kombination von ligasebestimmung und polymerase-kettenreaktion
|
US6780982B2
(en)
*
|
1996-07-12 |
2004-08-24 |
Third Wave Technologies, Inc. |
Charge tags and the separation of nucleic acid molecules
|
JP4000605B2
(ja)
|
1996-07-24 |
2007-10-31 |
株式会社日立製作所 |
Dna試料調整装置及びこれを用いる電気泳動分析装置
|
AU3829197A
(en)
*
|
1996-09-03 |
1998-03-26 |
Pioneer Hi-Bred International, Inc. |
Method and apparatus for single molecule two color fluorescent detection and molecular weight and concentration determination
|
US6133436A
(en)
|
1996-11-06 |
2000-10-17 |
Sequenom, Inc. |
Beads bound to a solid support and to nucleic acids
|
DE69735445T2
(de)
|
1996-12-10 |
2006-08-10 |
Sequenom, Inc., San Diego |
Abspaltbare, nicht-flüchtige moleküle zur massenmarkierung
|
US6299881B1
(en)
*
|
1997-03-24 |
2001-10-09 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
|
US20020015997A1
(en)
*
|
1997-06-16 |
2002-02-07 |
Lafferty William Michael |
Capillary array-based sample screening
|
US20030013115A1
(en)
*
|
1997-06-16 |
2003-01-16 |
Diversa Corporation, A Delaware Corporation |
Capillary array-based sample screening
|
US6559296B2
(en)
|
1997-08-29 |
2003-05-06 |
Olympus Optical Co., Ltd. |
DNA capillary
|
JP3938982B2
(ja)
*
|
1997-08-29 |
2007-06-27 |
オリンパス株式会社 |
Dnaキャピラリィ
|
US6008379A
(en)
|
1997-10-01 |
1999-12-28 |
The Perkin-Elmer Corporation |
Aromatic-substituted xanthene dyes
|
US6583168B1
(en)
|
1997-11-25 |
2003-06-24 |
Applera Corporation |
Sulfonated diarylrhodamine dyes
|
US5936087A
(en)
|
1997-11-25 |
1999-08-10 |
The Perkin-Elmer Corporation |
Dibenzorhodamine dyes
|
US6087102A
(en)
|
1998-01-07 |
2000-07-11 |
Clontech Laboratories, Inc. |
Polymeric arrays and methods for their use in binding assays
|
US6537749B2
(en)
*
|
1998-04-03 |
2003-03-25 |
Phylos, Inc. |
Addressable protein arrays
|
US6096875A
(en)
|
1998-05-29 |
2000-08-01 |
The Perlein-Elmer Corporation |
Nucleotide compounds including a rigid linker
|
CA2351739A1
(en)
*
|
1998-08-28 |
2000-03-09 |
Gryphon Sciences |
Polyamide chains of precise length, methods to manufacture them and their conjugates with proteins
|
US6238565B1
(en)
*
|
1998-09-16 |
2001-05-29 |
Varian, Inc. |
Monolithic matrix for separating bio-organic molecules
|
US7135284B1
(en)
*
|
1999-02-05 |
2006-11-14 |
Integrated Dna Technologies, Inc. |
Primer extension methods for production of high specific activity nucleic acid probes
|
US6635419B1
(en)
|
1999-02-16 |
2003-10-21 |
Applera Corporation |
Polynucleotide sequencing method
|
AU775179B2
(en)
|
1999-03-15 |
2004-07-22 |
Applied Biosystems, Llc |
Probe/mobility modifier complexes for multiplex nucleic acid detection
|
US7014994B1
(en)
|
1999-03-19 |
2006-03-21 |
Cornell Research Foundation,Inc. |
Coupled polymerase chain reaction-restriction-endonuclease digestion-ligase detection reaction process
|
US6506594B1
(en)
|
1999-03-19 |
2003-01-14 |
Cornell Res Foundation Inc |
Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
|
US6514700B1
(en)
*
|
1999-04-30 |
2003-02-04 |
Aclara Biosciences, Inc. |
Nucleic acid detection using degradation of a tagged sequence
|
US6322980B1
(en)
*
|
1999-04-30 |
2001-11-27 |
Aclara Biosciences, Inc. |
Single nucleotide detection using degradation of a fluorescent sequence
|
US6627400B1
(en)
|
1999-04-30 |
2003-09-30 |
Aclara Biosciences, Inc. |
Multiplexed measurement of membrane protein populations
|
US20040248150A1
(en)
*
|
1999-04-02 |
2004-12-09 |
Sharat Singh |
Methods employing oligonucleotide-binding e-tag probes
|
US20030235832A1
(en)
*
|
2000-06-21 |
2003-12-25 |
Ahmed Chenna |
Multiplexed analysis by chromatographic separation of molecular tags
|
US6673550B2
(en)
|
1999-04-30 |
2004-01-06 |
Aclara Biosciences, Inc. |
Electrophoretic tag reagents comprising fluorescent compounds
|
US7037654B2
(en)
|
1999-04-30 |
2006-05-02 |
Aclara Biosciences, Inc. |
Methods and compositions for enhancing detection in determinations employing cleavable electrophoretic tag reagents
|
US6649351B2
(en)
|
1999-04-30 |
2003-11-18 |
Aclara Biosciences, Inc. |
Methods for detecting a plurality of analytes by mass spectrometry
|
US7001725B2
(en)
|
1999-04-30 |
2006-02-21 |
Aclara Biosciences, Inc. |
Kits employing generalized target-binding e-tag probes
|
DE19924606A1
(de)
*
|
1999-05-28 |
2000-11-30 |
Graffinity Pharm Design Gmbh |
Ligand-Anker-Konjugate
|
US20020045182A1
(en)
*
|
1999-07-16 |
2002-04-18 |
Lynx Therapeutics, Inc. |
Multiplexed differential displacement for nucleic acid determinations
|
WO2001025481A1
(fr)
*
|
1999-10-04 |
2001-04-12 |
Olympus Optical Co., Ltd. |
Procede de detection d'acide nucleique
|
US7332275B2
(en)
|
1999-10-13 |
2008-02-19 |
Sequenom, Inc. |
Methods for detecting methylated nucleotides
|
EP1136569A3
(de)
|
2000-03-24 |
2004-01-28 |
Bayer Corporation |
Nukleinsäuresonden, die hoch-hydrophile nicht-nukleosidische Gruppen mit multiplen Markern enthalten und ihre Verwendungen
|
JP5508654B2
(ja)
|
2000-04-14 |
2014-06-04 |
コーネル・リサーチ・ファンデーション・インコーポレイテッド |
リガーゼ検出反応を用いた核酸配列の違いの検出のための位置特定可能なアレイの設計方法
|
US6329801B1
(en)
*
|
2000-04-24 |
2001-12-11 |
Volterra Semiconductor Corporation |
Switching regulator control system and method
|
US20030207300A1
(en)
*
|
2000-04-28 |
2003-11-06 |
Matray Tracy J. |
Multiplex analytical platform using molecular tags
|
US20040067498A1
(en)
*
|
2000-04-28 |
2004-04-08 |
Ahmed Chenna |
Detection of nucleic acid sequences by cleavage and separation of tag-containing structures
|
US20030170734A1
(en)
*
|
2000-04-28 |
2003-09-11 |
Stephen Williams |
Multiplexed assays using electrophoretically separated molecular tags
|
US7537938B2
(en)
*
|
2000-04-28 |
2009-05-26 |
Monogram Biosciences, Inc. |
Biomarker detection in circulating cells
|
US7160735B2
(en)
*
|
2000-04-28 |
2007-01-09 |
Monogram Biosciences, Inc. |
Tagged microparticle compositions and methods
|
US7771929B2
(en)
*
|
2000-04-28 |
2010-08-10 |
Monogram Biosciences, Inc. |
Tag library compounds, compositions, kits and methods of use
|
KR20030040208A
(ko)
*
|
2000-05-08 |
2003-05-22 |
큐티엘 바이오시스템즈 엘엘씨 |
개선된 형광 폴리머-qtl 바이오센싱 방법
|
EP1313880A2
(de)
*
|
2000-05-30 |
2003-05-28 |
PE Corporation (NY) |
Methoden zur detektion gewünschter nukleinsäuren mittels kombinierter ligation und amplifizierung
|
US6887664B2
(en)
|
2000-06-06 |
2005-05-03 |
Applera Corporation |
Asynchronous primed PCR
|
US6632606B1
(en)
|
2000-06-12 |
2003-10-14 |
Aclara Biosciences, Inc. |
Methods for single nucleotide polymorphism detection
|
US6958214B2
(en)
|
2000-07-10 |
2005-10-25 |
Sequenom, Inc. |
Polymorphic kinase anchor proteins and nucleic acids encoding the same
|
FR2812658B1
(fr)
*
|
2000-08-01 |
2005-04-15 |
De Bruno Vandiere |
Procede d'analyse d'acides nucleiques
|
AU2001296668A1
(en)
*
|
2000-10-05 |
2002-04-15 |
Aclara Biosciences, Inc. |
Multiplexed differential displacement for nucleic acid determinations
|
MXPA02005717A
(es)
*
|
2000-10-10 |
2003-10-14 |
Diversa Corp |
Analisis de alto rendimiento o a base de capilares para bioactividad o biomoleuclas.
|
US6811979B2
(en)
*
|
2000-10-11 |
2004-11-02 |
Applera Corporation |
Fluorescent nucleobase conjugates having anionic linkers
|
CA2435894C
(en)
*
|
2001-02-02 |
2014-05-13 |
Allvivo, Inc. |
End group activated polymers with oligonucleotide ligands
|
CA2440656A1
(en)
*
|
2001-03-09 |
2002-09-19 |
Apollo Biotechnology, Inc. |
Conjugate probes and optical detection of analytes
|
US6743905B2
(en)
*
|
2001-04-16 |
2004-06-01 |
Applera Corporation |
Mobility-modified nucleobase polymers and methods of using same
|
EP1386002A4
(de)
*
|
2001-04-16 |
2006-11-08 |
Applera Corp |
Verfahren und zusammensetzungen zur nukleotidanalyse
|
HUP0501021A3
(en)
|
2001-05-21 |
2006-06-28 |
Aclara Biosciences Inc Mountai |
Methods and compositions for analyzing proteins
|
WO2002095356A2
(en)
*
|
2001-05-21 |
2002-11-28 |
Aclara Biosciences, Inc. |
Methods and compositions for analyzing proteins
|
AU2002344221A1
(en)
*
|
2001-05-26 |
2002-12-09 |
Aclara Biosciences, Inc. |
Catalytic amplification of multiplexed assay signals
|
JP2005525787A
(ja)
*
|
2001-10-24 |
2005-09-02 |
シンギュレックス・インコーポレイテッド |
プローブとの相互作用による遺伝子ハプロタイプの検出方法
|
US7045311B2
(en)
*
|
2001-10-25 |
2006-05-16 |
Monogram Biosciences, Inc. |
Whole cell assay systems for cell surface proteases
|
CN1166422C
(zh)
*
|
2001-11-05 |
2004-09-15 |
北京源德生物医学工程股份有限公司 |
用于体外高能聚焦超声波治疗机的坐位架
|
US20030162202A1
(en)
*
|
2001-11-09 |
2003-08-28 |
Becker Kenneth David |
Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
|
US20040067512A1
(en)
*
|
2001-11-09 |
2004-04-08 |
Neurogenetics, Inc. |
Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
|
US20050053939A1
(en)
*
|
2001-11-09 |
2005-03-10 |
Ahmed Chenna |
Methods and compositions for enhancing detection in determinations employing cleavable electrophoretic tag reagents
|
JP2005517900A
(ja)
|
2001-11-21 |
2005-06-16 |
アプレラ コーポレイション |
デジタルアッセイ
|
EP1465998A2
(de)
|
2002-01-08 |
2004-10-13 |
Bayer HealthCare AG |
Herz-kreislauf-erkrankung und medikamentenwirkung voraussagende einzelnukleotid-polymorphismen
|
KR20040108655A
(ko)
*
|
2002-03-05 |
2004-12-24 |
아클라라 바이오사이언시스 인코퍼레이티드 |
막-결합된 민감제를 사용하는 복합 분석법
|
US20030177380A1
(en)
*
|
2002-03-18 |
2003-09-18 |
Woods Stanley P. |
Devices for storing array data and methods of using the same
|
JP2003294742A
(ja)
*
|
2002-03-29 |
2003-10-15 |
Inst Of Physical & Chemical Res |
ハイブリダイゼーション用基板及びその使用方法
|
EP1501863A4
(de)
*
|
2002-05-03 |
2007-01-24 |
Sequenom Inc |
Kinaseankerproteinmuteine, peptide davon und damit im zusammenhang stehende verfahren
|
US20040229299A1
(en)
*
|
2002-05-21 |
2004-11-18 |
Badal M. Youssouf |
Intracellular complexes as biomarkers
|
US7402397B2
(en)
*
|
2002-05-21 |
2008-07-22 |
Monogram Biosciences, Inc. |
Detecting and profiling molecular complexes
|
US20040229380A1
(en)
*
|
2002-05-21 |
2004-11-18 |
Po-Ying Chan-Hui |
ErbB heterodimers as biomarkers
|
US20040229293A1
(en)
*
|
2002-05-21 |
2004-11-18 |
Po-Ying Chan-Hui |
Surface receptor complexes as biomarkers
|
US20040229294A1
(en)
*
|
2002-05-21 |
2004-11-18 |
Po-Ying Chan-Hui |
ErbB surface receptor complexes as biomarkers
|
US20040175765A1
(en)
*
|
2002-07-05 |
2004-09-09 |
Sharat Singh |
Cell-screening assay and composition
|
PL374875A1
(en)
*
|
2002-07-25 |
2005-11-14 |
Aclara Biosciences, Inc. |
Detecting receptor oligomerization
|
JP2005534686A
(ja)
|
2002-07-31 |
2005-11-17 |
ユニバーシティ オブ サザン カリフォルニア |
疾患および処置結果の予見のための多型性
|
US7381317B2
(en)
|
2002-08-12 |
2008-06-03 |
Beckman Coulter, Inc. |
Methods and compositions for capillary electrophoresis (CE)
|
AU2003275138A1
(en)
|
2002-09-19 |
2004-04-08 |
Applied Biosystems, Llc. |
Methods and compositions for detecting targets
|
US20040235005A1
(en)
*
|
2002-10-23 |
2004-11-25 |
Ernest Friedlander |
Methods and composition for detecting targets
|
US20040091850A1
(en)
*
|
2002-11-08 |
2004-05-13 |
Travis Boone |
Single cell analysis of membrane molecules
|
WO2004046344A2
(en)
*
|
2002-11-19 |
2004-06-03 |
Applera Corporation |
Polynucleotide sequence detection assays
|
AU2003298672A1
(en)
*
|
2002-11-19 |
2005-01-28 |
Singulex, Inc. |
Detection of target molecules through interaction with probes
|
CA2505687A1
(en)
*
|
2002-11-19 |
2004-06-03 |
Applera Corporation |
Polynucleotide sequence detection assays and analysis
|
WO2005001129A2
(en)
*
|
2003-06-06 |
2005-01-06 |
Applera Corporation |
Mobility cassettes
|
US7402398B2
(en)
*
|
2003-07-17 |
2008-07-22 |
Monogram Biosciences, Inc. |
Measuring receptor homodimerization
|
WO2005019419A2
(en)
*
|
2003-07-31 |
2005-03-03 |
Singulex, Inc. |
Co-detection of single polypeptide and polynucleotide molecules
|
WO2005019470A2
(en)
*
|
2003-08-11 |
2005-03-03 |
Monogram Biosciences, Inc. |
Detecting and profiling molecular complexes
|
US7570443B2
(en)
|
2003-09-19 |
2009-08-04 |
Applied Biosystems, Llc |
Optical camera alignment
|
US20050112634A1
(en)
*
|
2003-09-19 |
2005-05-26 |
Woudenberg Timothy M. |
High density sequence detection methods and apparatus
|
CA2543830A1
(en)
*
|
2003-10-27 |
2005-05-19 |
Monogram Biosciences, Inc. |
Detecting human anti-therapeutic antibodies
|
US20050094807A1
(en)
*
|
2003-11-04 |
2005-05-05 |
John Silzel |
Accuracy array assay system and method
|
JP2007517511A
(ja)
*
|
2004-01-10 |
2007-07-05 |
バイエル・ヘルスケア・エルエルシー |
ヒトチオプリンs−メチルトランスフェラーゼ欠損に関連するハプロタイプおよび多型
|
WO2005098040A2
(en)
*
|
2004-03-24 |
2005-10-20 |
Applera Corporation |
Ligation and amplification reactions for determining target molecules
|
US20050255485A1
(en)
*
|
2004-05-14 |
2005-11-17 |
Livak Kenneth J |
Detection of gene duplications
|
CA2572450A1
(en)
|
2004-05-28 |
2005-12-15 |
Ambion, Inc. |
Methods and compositions involving microrna
|
US20060003337A1
(en)
*
|
2004-06-30 |
2006-01-05 |
John Brandis |
Detection of small RNAS
|
WO2006012361A2
(en)
|
2004-07-01 |
2006-02-02 |
University Of Southern California |
Genetic markers for predicting disease and treatment outcome
|
EP2302055B1
(de)
|
2004-11-12 |
2014-08-27 |
Asuragen, Inc. |
Verfahren und Zusammensetzungen, die miRNAs und miRNAa-inhibitorischen Molekülen verbunden sind
|
JP2008527979A
(ja)
*
|
2005-01-12 |
2008-07-31 |
アプレラ コーポレイション |
核酸の選択的増幅のための組成物、方法およびキット
|
EP2604703B1
(de)
|
2005-03-14 |
2017-02-01 |
The Board of Trustees of the Leland Stanford Junior University |
Verfahren zur Bewertung der Haltbarkeit eines Pfropfs im Körper eines Empfängers fester Organtransplantate
|
US20060211030A1
(en)
*
|
2005-03-16 |
2006-09-21 |
Sydney Brenner |
Methods and compositions for assay readouts on multiple analytical platforms
|
EP1902142B1
(de)
|
2005-04-14 |
2010-01-06 |
Applied Biosystems, LLC |
3'-modifizierte oligonukleotide mit pseudoisocytosin-nukleobasenderivaten sowie deren anwendungen als primer oder sonden
|
EP1731620A1
(de)
|
2005-06-07 |
2006-12-13 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Methode zur Diagnose von Immun-Transplantatstoleranz
|
US20070087360A1
(en)
*
|
2005-06-20 |
2007-04-19 |
Boyd Victoria L |
Methods and compositions for detecting nucleotides
|
US20070014699A1
(en)
*
|
2005-06-23 |
2007-01-18 |
Beckman Coulter, Inc, |
Methods and apparatus for improving the sensitivity of capillary zone electrophoresis
|
US20070026439A1
(en)
*
|
2005-07-15 |
2007-02-01 |
Applera Corporation |
Fluid processing device and method
|
US20070099211A1
(en)
*
|
2005-07-15 |
2007-05-03 |
Vissarion Aivazachvili |
Detection of nucleic acid amplification
|
EP2311995A1
(de)
|
2005-09-22 |
2011-04-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Verfahren zur Verwendung IL-21
|
US20070202515A1
(en)
*
|
2005-10-12 |
2007-08-30 |
Pathologica, Llc. |
Promac signature application
|
WO2007103814A2
(en)
|
2006-03-03 |
2007-09-13 |
University Of Southern California |
Angiogenesis pathway gene polymorphisms for therapy selection
|
US20070215472A1
(en)
*
|
2006-03-15 |
2007-09-20 |
Slater Gary W |
Electroosmotic flow for end labelled free solution electrophoresis
|
US20070218494A1
(en)
*
|
2006-03-17 |
2007-09-20 |
Gary Slater |
Branched polymer lables as drag-tags in free solution electrophoresis
|
US7759062B2
(en)
*
|
2006-06-09 |
2010-07-20 |
Third Wave Technologies, Inc. |
T-structure invasive cleavage assays, consistent nucleic acid dispensing, and low level target nucleic acid detection
|
EP2442108B1
(de)
|
2006-07-14 |
2016-11-16 |
The Regents of The University of California |
Krebsbiomarker und Anwendungsverfahren dafür
|
EP2145001A2
(de)
|
2006-09-19 |
2010-01-20 |
Asuragen, Inc. |
Von mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p regulierte gene und stoffwechselwege als ziele für einen therapeutischen eingriff
|
WO2008036765A2
(en)
|
2006-09-19 |
2008-03-27 |
Asuragen, Inc. |
Micrornas differentially expressed in pancreatic diseases and uses thereof
|
WO2008076842A2
(en)
*
|
2006-12-14 |
2008-06-26 |
Applied Biosystems Inc. |
Sequencing methods
|
US8114599B2
(en)
|
2006-12-19 |
2012-02-14 |
Northwestern University |
Compositions and methods for free-solution conjugate nucleic acid analysis
|
WO2008088860A2
(en)
|
2007-01-18 |
2008-07-24 |
University Of Southern California |
Polymorphisms in the egfr pathway as markers for cancer treatment
|
EP2126117A2
(de)
*
|
2007-01-18 |
2009-12-02 |
University Of Southern California |
Für duale tki-therapie prädiktive genpoylmorphismen
|
EP2107911A4
(de)
|
2007-01-30 |
2010-09-22 |
Pharmacyclics Inc |
Verfahren zur bestimmung der krebsresistenz auf histon-deacetylasehemmer
|
FI20075124A0
(fi)
*
|
2007-02-21 |
2007-02-21 |
Valtion Teknillinen |
Menetelmä ja testikitti nukleotidivariaatioiden toteamiseksi
|
EP1961825A1
(de)
|
2007-02-26 |
2008-08-27 |
INSERM (Institut National de la Santé et de la Recherche Medicale) |
Verfahren zur Vorhersage des Auftretens von Metastasen bei Brustkrebspatienten
|
PL2121989T5
(pl)
|
2007-03-13 |
2023-03-06 |
Amgen Inc. |
Mutacje K-RAS oraz terapia przeciwciałem anty-EGFR
|
AR065686A1
(es)
|
2007-03-13 |
2009-06-24 |
Amgen Inc |
Mutaciones de k- ras y b- raf y terapia con anticuerpos anti- egfr
|
WO2009020682A2
(en)
|
2007-05-08 |
2009-02-12 |
The Trustees Of Boston University |
Chemical functionalization of solid-state nanopores and nanopore arrays and applications thereof
|
US8008010B1
(en)
|
2007-06-27 |
2011-08-30 |
Applied Biosystems, Llc |
Chimeric oligonucleotides for ligation-enhanced nucleic acid detection, methods and compositions therefor
|
CA2706763C
(en)
*
|
2007-11-27 |
2013-07-30 |
Laboratory Corporation Of America Holdings |
Enhanced method for detecting and/or quantifying an analyte in a sample
|
WO2009097424A1
(en)
*
|
2008-01-29 |
2009-08-06 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Fstl-1 as a biomarker of inflammation
|
US8658379B2
(en)
|
2008-01-29 |
2014-02-25 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Follistatin-like protein-1 as a biomarker for sepsis
|
EP2113574A1
(de)
|
2008-04-28 |
2009-11-04 |
Biotype AG |
Stoffe und Verfahren für Profilierungstest auf DNA-Basis
|
EP2990487A1
(de)
|
2008-05-08 |
2016-03-02 |
Asuragen, INC. |
Zusammensetzungen und verfahren in zusammenhang mit der mirna-modulation von neovaskularisation oder angiogenese
|
US20110111417A1
(en)
|
2008-05-14 |
2011-05-12 |
Millennium Pharmaceuticals, Inc. |
Methods and kits for monitoring the effects of immunomodulators on adaptive immunity
|
WO2009145802A1
(en)
*
|
2008-05-30 |
2009-12-03 |
The Trustess Of Columbia University In The City Of New York |
Systems and methods for integrating a single dna molecule into a molecular electronic device
|
US8208909B2
(en)
|
2008-06-02 |
2012-06-26 |
West Corporation |
System, apparatus and method for availing a mobile call of address information
|
US20110201519A1
(en)
|
2008-08-18 |
2011-08-18 |
Sarwal Minnie M |
Methods and Compositions for Determining a Graft Tolerant Phenotype in a Subject
|
WO2010065517A1
(en)
|
2008-12-01 |
2010-06-10 |
The Trustees Of Columbia University In The City Of New York |
Electromechanical devices and methods for fabrication of the same
|
DE102009010563A1
(de)
|
2009-02-16 |
2010-08-26 |
Matthias W. Engel |
Vorrichtung zum Nachweis von Analyten in Körperflüssigkeiten
|
WO2010123625A1
(en)
|
2009-04-24 |
2010-10-28 |
University Of Southern California |
Cd133 polymorphisms predict clinical outcome in patients with cancer
|
WO2011004345A1
(en)
|
2009-07-09 |
2011-01-13 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Upstream binding protein 1 polymorphisms and their use for prognosing or diagnosing arterial blood pressure
|
CN104293646A
(zh)
|
2009-08-22 |
2015-01-21 |
里兰斯坦福初级大学理事会 |
成像并评估胚胎、卵母细胞和干细胞
|
AU2010301128B2
(en)
|
2009-09-30 |
2014-09-18 |
Quantapore, Inc. |
Ultrafast sequencing of biological polymers using a labeled nanopore
|
JP2013510564A
(ja)
|
2009-11-13 |
2013-03-28 |
パンガエア ビオテック、ソシエダッド、リミターダ |
肺癌におけるチロシンキナーゼ阻害剤に対する応答を予測するための分子バイオマーカー
|
WO2011068829A1
(en)
|
2009-12-02 |
2011-06-09 |
The Board Of Trustees Of The Leland Stanford Junior University |
Biomarkers for determining an allograft tolerant phenotype
|
GB0922085D0
(en)
|
2009-12-17 |
2010-02-03 |
Cambridge Entpr Ltd |
Cancer diagnosis and treatment
|
WO2011084757A1
(en)
|
2009-12-21 |
2011-07-14 |
University Of Southern California |
Germline polymorphisms in the sparc gene associated with clinical outcome in gastric cancer
|
WO2011085334A1
(en)
|
2010-01-11 |
2011-07-14 |
University Of Southern California |
Cd44 polymorphisms predict clinical outcome in patients with gastric cancer
|
TWI518325B
(zh)
|
2010-02-04 |
2016-01-21 |
自治醫科大學 |
對alk抑制劑具有先抗性或後抗性癌症的識別、判斷和治療
|
EP3214174B1
(de)
|
2010-03-04 |
2019-10-16 |
InteRNA Technologies B.V. |
Mirna-molekül, das über seine quelle definiert ist, und seine diagnostischen und therapeutischen verwendungen bei mit emt assoziierten krankheiten
|
WO2011133538A1
(en)
|
2010-04-19 |
2011-10-27 |
The Procter & Gamble Company |
Genetic signatures and gene chips associated with administration of electrically conducted radio frequency current to skin and methods and treatments relating thereto
|
BR112012026871A2
(pt)
|
2010-04-19 |
2017-06-06 |
Procter & Gamble |
aplicação combinada de composição tópica e de energia para regular a condição de pele de mamíferos
|
EP3508854A1
(de)
|
2010-04-27 |
2019-07-10 |
The Regents of The University of California |
Krebsbiomarker und verfahren zur verwendung davon
|
WO2011143556A1
(en)
*
|
2010-05-13 |
2011-11-17 |
Gen9, Inc. |
Methods for nucleotide sequencing and high fidelity polynucleotide synthesis
|
WO2011146725A1
(en)
|
2010-05-19 |
2011-11-24 |
Bayer Healthcare Llc |
Biomarkers for a multikinase inhibitor
|
US8586301B2
(en)
|
2010-06-30 |
2013-11-19 |
Stratos Genomics, Inc. |
Multiplexed identification of nucleic acid sequences
|
NZ704322A
(en)
|
2010-07-06 |
2016-07-29 |
Interna Technologies Bv |
Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway
|
WO2012019099A2
(en)
|
2010-08-05 |
2012-02-09 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Follistatin-like-protein-1 as a biomarker for inflammatory disorders
|
KR20130115250A
(ko)
|
2010-09-15 |
2013-10-21 |
알막 다이아그노스틱스 리미티드 |
암에 대한 분자적 진단 테스트
|
WO2012051301A1
(en)
|
2010-10-12 |
2012-04-19 |
President And Fellows Of Harvard College |
Methods for identifying modulators of triglyceride metabolism, for modulating triglyceride metabolism and for identifying subjects at risk for abnormal triglyceride metabolism
|
CA2817882C
(en)
|
2010-11-17 |
2022-08-23 |
Asuragen, Inc. |
Mirnas as biomarkers for distinguishing benign from malignant thyroid neoplasms
|
EP2474617A1
(de)
|
2011-01-11 |
2012-07-11 |
InteRNA Technologies BV |
MIR zur Behandlung von Neoangiogenese
|
US8486717B2
(en)
|
2011-01-18 |
2013-07-16 |
Symbolics, Llc |
Lateral flow assays using two dimensional features
|
EP2492688A1
(de)
|
2011-02-23 |
2012-08-29 |
Pangaea Biotech, S.A. |
Molekulare Biomarker zur Vorhersage der Reaktion auf die Antitumorbehandlung bei Lungenkrebs
|
WO2012116185A1
(en)
|
2011-02-23 |
2012-08-30 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods of detecting aneuploidy in human embryos
|
WO2012158238A2
(en)
|
2011-02-28 |
2012-11-22 |
University Of Iowa Research Foundation |
Anti-müllerian hormone changes in pregnancy and prediction ofadverse pregnancy outcomes and gender
|
EA027558B1
(ru)
|
2011-05-19 |
2017-08-31 |
Эйджена Байосайенс, Инк. |
Способ обнаружения мультиплексных нуклеиновых кислот
|
US10260097B2
(en)
|
2011-06-02 |
2019-04-16 |
Almac Diagnostics Limited |
Method of using a gene expression profile to determine cancer responsiveness to an anti-angiogenic agent
|
US9644241B2
(en)
|
2011-09-13 |
2017-05-09 |
Interpace Diagnostics, Llc |
Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease
|
WO2013063519A1
(en)
|
2011-10-26 |
2013-05-02 |
Asuragen, Inc. |
Methods and compositions involving mirna expression levels for distinguishing pancreatic cysts
|
WO2013063544A1
(en)
|
2011-10-27 |
2013-05-02 |
Asuragen, Inc. |
Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors
|
CN104302180B
(zh)
|
2011-10-28 |
2017-05-17 |
米伦纽姆医药公司 |
对nedd8活化酶(nae)抑制剂的反应的生物标记
|
JP6397765B2
(ja)
|
2011-11-11 |
2018-09-26 |
ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. |
プロテアソーム阻害剤に応答するバイオマーカー
|
WO2013071163A2
(en)
|
2011-11-11 |
2013-05-16 |
Millennium Pharamaceuticals, Inc. |
Biomarkers of response to proteasome inhibitors
|
WO2013087789A1
(en)
|
2011-12-13 |
2013-06-20 |
Glykos Finland Ltd. |
Antibody isoform arrays and methods thereof
|
WO2014007623A1
(en)
|
2012-07-03 |
2014-01-09 |
Interna Technologies B.V. |
Diagnostic portfolio and its uses
|
EP2875131B1
(de)
|
2012-07-18 |
2018-03-14 |
Siemens Healthcare Diagnostics Inc. |
Verfahren zur normalisierung von biologischen proben
|
US9874556B2
(en)
|
2012-07-18 |
2018-01-23 |
Symbolics, Llc |
Lateral flow assays using two dimensional features
|
EP3418395A1
(de)
|
2012-09-06 |
2018-12-26 |
Life Technologies Corporation |
Multiplex-y-str-analyse
|
CA2886783A1
(en)
|
2012-10-01 |
2014-04-10 |
Millennium Pharmaceuticals, Inc. |
Biomarkers and methods to predict response to inhibitors and uses thereof
|
WO2014055117A1
(en)
|
2012-10-04 |
2014-04-10 |
Asuragen, Inc. |
Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions
|
US10206911B2
(en)
|
2012-10-26 |
2019-02-19 |
Memorial Sloan-Kettering Cancer Center |
Androgen receptor variants and methods for making and using
|
US9651539B2
(en)
|
2012-10-28 |
2017-05-16 |
Quantapore, Inc. |
Reducing background fluorescence in MEMS materials by low energy ion beam treatment
|
RS56680B1
(sr)
|
2012-11-28 |
2018-03-30 |
Merck Sharp & Dohme |
Kompozicije i postupci za lečenje kancera
|
EP2925885B1
(de)
|
2012-12-03 |
2020-02-05 |
Almac Diagnostic Services Limited |
Molekular-diagnosetest für krebs
|
US9868992B2
(en)
|
2013-03-15 |
2018-01-16 |
Baylor Research Institute |
Tissue and blood-based miRNA biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer
|
EP2970909A4
(de)
|
2013-03-15 |
2017-02-15 |
The University of Chicago |
Verfahren und zusammensetzungen in zusammenhang mit t-zell aktivität
|
WO2014151551A1
(en)
|
2013-03-15 |
2014-09-25 |
Baylor Research Institute |
Ulcerative colitis (uc)-associated colorectal neoplasia markers
|
AU2014268322B2
(en)
|
2013-05-24 |
2019-01-24 |
Quantapore, Inc. |
Nanopore-based nucleic acid analysis with mixed FRET detection
|
EP2805769A1
(de)
|
2013-05-24 |
2014-11-26 |
European Molecular Biology Laboratory |
Verfahren zur nanoskaligen Einzelzellenanalyse
|
WO2014201155A1
(en)
|
2013-06-11 |
2014-12-18 |
Courtagen Life Sciences, Inc. |
Methods and kits for treating and classifying individuals at risk of or suffering from trap1 change-of-function
|
KR102291045B1
(ko)
|
2013-08-05 |
2021-08-19 |
트위스트 바이오사이언스 코포레이션 |
드 노보 합성된 유전자 라이브러리
|
CN108051590B
(zh)
|
2013-09-13 |
2020-12-11 |
Symbolics有限责任公司 |
运用二维试验和对照信号读出模式的侧向层析检测
|
EP3084003A4
(de)
|
2013-12-17 |
2017-07-19 |
Merck Sharp & Dohme Corp. |
Ifn-gamma-gensignaturbiomarker der tumorreaktion auf pd-1 antagonisten
|
GB201409479D0
(en)
|
2014-05-28 |
2014-07-09 |
Almac Diagnostics Ltd |
Molecular diagnostic test for cancer
|
US10328062B2
(en)
|
2014-04-04 |
2019-06-25 |
Amgen, Inc. |
Biomarkers and use of MET inhibitor for treatment of cancer
|
EP3194623B1
(de)
|
2014-08-12 |
2022-01-05 |
Wayne State University |
Systeme und verfahren zur erkennung von stress von stammzellen und verwendungen davon
|
US9885079B2
(en)
|
2014-10-10 |
2018-02-06 |
Quantapore, Inc. |
Nanopore-based polymer analysis with mutually-quenching fluorescent labels
|
GB201418892D0
(en)
*
|
2014-10-23 |
2014-12-10 |
Proqr Therapeutics B V |
DNA editing
|
EP3209800B1
(de)
|
2014-10-24 |
2022-02-16 |
Quantapore, Inc. |
Effiziente optische analyse von polymeren unter verwendung von nanostrukturanordnungen
|
WO2016090323A1
(en)
|
2014-12-05 |
2016-06-09 |
Prelude, Inc. |
Dcis recurrence and invasive breast cancer
|
CA2968406A1
(en)
|
2014-12-09 |
2016-06-16 |
Mark D. Ayers |
System and methods for deriving gene signature biomarkers of response to pd-1 antagonists
|
CA2975855A1
(en)
|
2015-02-04 |
2016-08-11 |
Twist Bioscience Corporation |
Compositions and methods for synthetic gene assembly
|
CA2975852A1
(en)
|
2015-02-04 |
2016-08-11 |
Twist Bioscience Corporation |
Methods and devices for de novo oligonucleic acid assembly
|
EP3839510A3
(de)
|
2015-04-17 |
2021-08-25 |
Merck Sharp & Dohme Corp. |
Blutbasierte biomarker der tumorempfindlichkeit gegen pd-1-antagonisten
|
WO2016172377A1
(en)
|
2015-04-21 |
2016-10-27 |
Twist Bioscience Corporation |
Devices and methods for oligonucleic acid library synthesis
|
CN107406882B
(zh)
|
2015-04-24 |
2022-03-01 |
基纳生物技术有限公司 |
用于次要等位基因和多态性的鉴定和定量的多重化方法
|
WO2016172579A1
(en)
|
2015-04-24 |
2016-10-27 |
Agena Bioscience, Inc, |
Multiplex methods for detection and quantification of minor variants
|
GB201512869D0
(en)
|
2015-07-21 |
2015-09-02 |
Almac Diagnostics Ltd |
Gene signature for minute therapies
|
KR20180050411A
(ko)
|
2015-09-18 |
2018-05-14 |
트위스트 바이오사이언스 코포레이션 |
올리고핵산 변이체 라이브러리 및 그의 합성
|
CN113604546A
(zh)
|
2015-09-22 |
2021-11-05 |
特韦斯特生物科学公司 |
用于核酸合成的柔性基底
|
WO2017095958A1
(en)
|
2015-12-01 |
2017-06-08 |
Twist Bioscience Corporation |
Functionalized surfaces and preparation thereof
|
CN109073654A
(zh)
|
2016-04-20 |
2018-12-21 |
苏州爱尔迪思生物科技有限公司 |
用于预测早产的方法和组合物
|
CN109196362A
(zh)
|
2016-05-17 |
2019-01-11 |
苏州爱尔迪思生物科技有限公司 |
用于提供子痫前期评估的方法和组合物
|
EP3482196B1
(de)
|
2016-07-05 |
2022-02-23 |
Quantapore, Inc. |
Optisch basierte nanoporensequenzierung
|
WO2018038772A1
(en)
|
2016-08-22 |
2018-03-01 |
Twist Bioscience Corporation |
De novo synthesized nucleic acid libraries
|
KR102217487B1
(ko)
|
2016-09-21 |
2021-02-23 |
트위스트 바이오사이언스 코포레이션 |
핵산 기반 데이터 저장
|
EA201991262A1
(ru)
|
2016-12-16 |
2020-04-07 |
Твист Байосайенс Корпорейшн |
Библиотеки вариантов иммунологического синапса и их синтез
|
CA3054303A1
(en)
|
2017-02-22 |
2018-08-30 |
Twist Bioscience Corporation |
Nucleic acid based data storage
|
CA3056388A1
(en)
|
2017-03-15 |
2018-09-20 |
Twist Bioscience Corporation |
Variant libraries of the immunological synapse and synthesis thereof
|
WO2018186930A1
(en)
*
|
2017-04-06 |
2018-10-11 |
MyOmicsDx, Inc |
Method and kit for constructing nucleic acid library
|
WO2018186947A1
(en)
*
|
2017-04-06 |
2018-10-11 |
MyOmicsDx, Inc |
Method and kit for targeted enrichment of nucleic acids
|
CA3057157A1
(en)
|
2017-04-28 |
2018-11-01 |
Merck Sharp & Dohme Corp. |
Biomarkers for cancer therapeutics
|
KR20240013290A
(ko)
|
2017-06-12 |
2024-01-30 |
트위스트 바이오사이언스 코포레이션 |
심리스 핵산 어셈블리를 위한 방법
|
WO2018231864A1
(en)
|
2017-06-12 |
2018-12-20 |
Twist Bioscience Corporation |
Methods for seamless nucleic acid assembly
|
GB2581620A
(en)
|
2017-09-11 |
2020-08-26 |
Twist Bioscience Corp |
GPCR binding proteins and synthesis thereof
|
CN111565834B
(zh)
|
2017-10-20 |
2022-08-26 |
特韦斯特生物科学公司 |
用于多核苷酸合成的加热的纳米孔
|
CA3079524A1
(en)
|
2017-11-03 |
2019-05-09 |
Interna Technologies B.V. |
Mirna molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation
|
WO2019109016A1
(en)
|
2017-12-01 |
2019-06-06 |
Millennium Pharmaceuticals, Inc. |
Biomarkers and methods for treatment with nae inhibitors
|
EP3735459A4
(de)
|
2018-01-04 |
2021-10-06 |
Twist Bioscience Corporation |
Digitale informationsspeicherung auf dna-basis
|
US11957695B2
(en)
|
2018-04-26 |
2024-04-16 |
The Broad Institute, Inc. |
Methods and compositions targeting glucocorticoid signaling for modulating immune responses
|
WO2019213660A2
(en)
|
2018-05-04 |
2019-11-07 |
The Broad Institute, Inc. |
Compositions and methods for modulating cgrp signaling to regulate innate lymphoid cell inflammatory responses
|
CA3100739A1
(en)
|
2018-05-18 |
2019-11-21 |
Twist Bioscience Corporation |
Polynucleotides, reagents, and methods for nucleic acid hybridization
|
WO2020036926A1
(en)
|
2018-08-17 |
2020-02-20 |
Cellecta, Inc. |
Multiplex preparation of barcoded gene specific dna fragments
|
CA3112792A1
(en)
|
2018-09-14 |
2020-03-19 |
Prelude Corporation |
Method of selection for treatment of subjects at risk of invasive breast cancer
|
US20220401460A1
(en)
|
2018-10-10 |
2022-12-22 |
Dana-Farber Cancer Institute, Inc. |
Modulating resistance to bcl-2 inhibitors
|
EP3930753A4
(de)
|
2019-02-26 |
2023-03-29 |
Twist Bioscience Corporation |
Variante nukleinsäurebibliotheken für glp1-rezeptor
|
KR20210144698A
(ko)
|
2019-02-26 |
2021-11-30 |
트위스트 바이오사이언스 코포레이션 |
항체 최적화를 위한 변이 핵산 라이브러리
|
AU2020228047A1
(en)
|
2019-02-27 |
2021-09-30 |
Madera Therapeutics, LLC |
Use of caseinolytic protease P function as a biomarker of drug response to imipridone-like agents
|
WO2020186101A1
(en)
|
2019-03-12 |
2020-09-17 |
The Broad Institute, Inc. |
Detection means, compositions and methods for modulating synovial sarcoma cells
|
US20220143148A1
(en)
|
2019-03-14 |
2022-05-12 |
The Broad Institute, Inc. |
Compositions and methods for modulating cgrp signaling to regulate intestinal innate lymphoid cells
|
US20220142948A1
(en)
|
2019-03-18 |
2022-05-12 |
The Broad Institute, Inc. |
Compositions and methods for modulating metabolic regulators of t cell pathogenicity
|
US20220152148A1
(en)
|
2019-03-18 |
2022-05-19 |
The Broad Institute, Inc. |
Modulation of type 2 immunity by targeting clec-2 signaling
|
WO2020210521A2
(en)
|
2019-04-12 |
2020-10-15 |
The Regents Of The University Of California |
Compositions and methods for increasing muscle mass and oxidative metabolism
|
CN114729342A
(zh)
|
2019-06-21 |
2022-07-08 |
特韦斯特生物科学公司 |
基于条形码的核酸序列装配
|
WO2021030627A1
(en)
|
2019-08-13 |
2021-02-18 |
The General Hospital Corporation |
Methods for predicting outcomes of checkpoint inhibition and treatment thereof
|
CN110470760A
(zh)
*
|
2019-08-16 |
2019-11-19 |
谱尼测试集团吉林有限公司 |
塑料制品中聚乳酸含量的检测方法
|
US11793787B2
(en)
|
2019-10-07 |
2023-10-24 |
The Broad Institute, Inc. |
Methods and compositions for enhancing anti-tumor immunity by targeting steroidogenesis
|
US11844800B2
(en)
|
2019-10-30 |
2023-12-19 |
Massachusetts Institute Of Technology |
Methods and compositions for predicting and preventing relapse of acute lymphoblastic leukemia
|
US20230044602A1
(en)
|
2019-12-20 |
2023-02-09 |
EDWARD Via COLLEGE OF OSTEOPATHIC MEDICINE |
Cancer signatures, methods of generating cancer signatures, and uses thereof
|
WO2022192419A2
(en)
|
2021-03-09 |
2022-09-15 |
Massachusetts Institute Of Technology |
Methods of treating inflammatory bowel disease (ibd) with anti- tnf-blockade
|
WO2023158732A1
(en)
|
2022-02-16 |
2023-08-24 |
Dana-Farber Cancer Institute, Inc. |
Methods for decreasing pathologic alpha-synuclein using agents that modulate fndc5 or biologically active fragments thereof
|
WO2024028794A1
(en)
|
2022-08-02 |
2024-02-08 |
Temple Therapeutics BV |
Methods for treating endometrial and ovarian hyperproliferative disorders
|